ARID1A and breast cancer: Our analysis revealed that PIK3CA mutations, as well as ARID1A-PIK3CA mutational co-occurrence, were significantly more common (p ≤ 0.05) in luminal tumors than in other BC subtypes (Fig. 2a,b).